The role of specific genomic alterations in small cell lung cancer aggressiveness
Small Cell Lung Cancer (SCLC) is a very aggressive neuroendocrine tumour of the lung, which demonstrates a 5 year survival of only 10% for extensive stage disease (20-30% for limited stage), with only modest improvement over the last few decades. Identification of new molecular diagnostic and therap...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
University of British Columbia
2008
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2429/2283 |